Pure Global

Glycosylated Hemoglobin A1c Assay (Glycosylated Hemoglobin A1c Assay ) - India CDSCO Medical Device Registration

Glycosylated Hemoglobin A1c Assay (Glycosylated Hemoglobin A1c Assay ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000207_65d781c08abe3dc4d632b27df06e7bcf_55a75f39b28992322d7f4d42a667bee6. This device is marketed under the brand name CLIA. The license holder is Rapid House, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Glycosylated Hemoglobin A1c Assay (Glycosylated Hemoglobin A1c Assay )
UID: IMP/IVD/2023/000207_65d781c08abe3dc4d632b27df06e7bcf_55a75f39b28992322d7f4d42a667bee6

Brand Name

CLIA

License Holder

Rapid House

Device Class

Class B

Approving Authority

CDSCO

Product Information

The kit is used for the quantitative in vitro detection of Glycosylated Hemoglobin A1c in human whole blood samples

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing